Central Nervous System Stimulants

"Central Nervous System Stimulants" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here.

Descriptor ID	D000697
MeSH Number(s)	D27.505.696.282 D27.505.954.427.220
Concept/Terms	Central Nervous System Stimulants Central Nervous System Stimulants Central Stimulants Stimulants, Central Analeptics Analeptics Analeptic Drugs Drugs, Analeptic Analeptic Agents Agents, Analeptic

Below are MeSH descriptors whose meaning is more general than "Central Nervous System Stimulants".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Physiological Effects of Drugs [D27.505.696]
Central Nervous System Stimulants [D27.505.696.282]
Therapeutic Uses [D27.505.954]
Central Nervous System Agents [D27.505.954.427]
Central Nervous System Stimulants [D27.505.954.427.220]

Below are MeSH descriptors whose meaning is related to "Central Nervous System Stimulants".

Below are MeSH descriptors whose meaning is more specific than "Central Nervous System Stimulants".

Central Nervous System Stimulants
Aphrodisiacs
Appetite Stimulants
Convulsants

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Central Nervous System Stimulants" by people in this website by year, and whether "Central Nervous System Stimulants" was a major or minor topic of these publications.

Bar chart showing 68 publications over 23 distinct years, with a maximum of 9 publications in 2012

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2000	1	0	1
2001	2	0	2
2002	1	1	2
2003	1	0	1
2004	3	0	3
2005	1	0	1
2006	2	1	3
2007	4	0	4
2008	3	0	3
2009	2	1	3
2010	2	0	2
2011	1	2	3
2012	6	3	9
2013	4	2	6
2014	4	0	4
2015	3	2	5
2016	6	0	6
2017	1	1	2
2018	1	0	1
2019	1	1	2
2020	0	1	1
2021	1	2	3
2022	1	0	1

Below are the most recent publications written about "Central Nervous System Stimulants" by people in Profiles.

Mohr ALA, Logan BK, Fogarty MF, Krotulski AJ, Papsun DM, Kacinko SL, Huestis MA, Ropero-Miller JD. Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017-2020: A Review. J Anal Toxicol. 2022 Jul 14; 46(6):e116-e185.

View in: PubMed
Reich JS, Sethi HK, Sataloff RT. Bilateral Sensorineural Hearing Loss in the Setting of Acute Methamphetamine Overdose. Ear Nose Throat J. 2024 Aug; 103(8):NP491-NP493.

View in: PubMed
Tuv SS, Bergh MS, Andersen JM, Steinsland S, Vindenes V, Baumann MH, Huestis MA, Bogen IL. Comparative Neuropharmacology and Pharmacokinetics of Methamphetamine and Its Thiophene Analog Methiopropamine in Rodents. Int J Mol Sci. 2021 Nov 05; 22(21).

View in: PubMed
La Maida N, Di Trana A, Giorgetti R, Tagliabracci A, Busard? FP, Huestis MA. A Review of Synthetic Cathinone-Related Fatalities From 2017 to 2020. Ther Drug Monit. 2021 02 01; 43(1):52-68.

View in: PubMed
Chu EK, Smith LM, Derauf C, Newman E, Neal CR, Arria AM, Huestis MA, DellaGrotta SA, Roberts MB, Dansereau LM, Lester BM. Behavior Problems During Early Childhood in Children With Prenatal Methamphetamine Exposure. Pediatrics. 2020 12; 146(6).

View in: PubMed
Kohl BA, Kaur K, Dincher N, Schumann J, Carachilo T, Komurek C. Acute intentional caffeine overdose treated preemptively with hemodialysis. Am J Emerg Med. 2020 03; 38(3):692.e1-692.e3.

View in: PubMed
Yates JR, Prior NA, Chitwood MR, Day HA, Heidel JR, Hopkins SE, Muncie BT, Paradella-Bradley TA, Sestito AP, Vecchiola AN, Wells EE. Using a dependent schedule to measure risky choice in male rats: Effects of d-amphetamine, methylphenidate, and methamphetamine. Exp Clin Psychopharmacol. 2020 Apr; 28(2):181-195.

View in: PubMed
Richards C, Iosifescu DV, Mago R, Sarkis E, Geibel B, Dauphin M, McIntyre RS, Weisler R, Brawman-Mintzer O, Gu J, Madhoo M. A 12-Month Open-Label Extension Study of the Safety and Tolerability of Lisdexamfetamine Dimesylate for Major Depressive Disorder in Adults. J Clin Psychopharmacol. 2018 Aug; 38(4):336-343.

View in: PubMed
Logan BK, Mohr ALA, Friscia M, Krotulski AJ, Papsun DM, Kacinko SL, Ropero-Miller JD, Huestis MA. Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013-2016: A Review. J Anal Toxicol. 2017 Sep 01; 41(7):573-610.

View in: PubMed
Hart T, Whyte J, Watanabe T, Chervoneva I. Effects of dextroamphetamine in subacute traumatic brain injury: A randomized, placebo-controlled pilot study. J Neurosci Res. 2018 04; 96(4):702-710.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement